Leber, MF, Efferth, T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol 2009, 34:881–895.
Nowell, PC. The clonal evolution of tumor cell populations. Science 1976, 194:23–28.
Talmadge, JE. Clonal selection of metastasis within the life history of a tumor. Cancer Res 2007, 67:11471–11475. doi: 10.1158/0008‐5472.CAN‐07‐2496.
Ruiz, C, Lenkiewicz, E, Evers, L, Holley, T, Robeson, A, Kiefer, J, Demeure, MJ, Hollingsworth, MA, Shen, M, Prunkard, D, et al. Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci USA 2011, 108:12054–12059. doi: 10.1073/pnas.1104009108.
Fidler, IJ, Kripke, ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977, 197:893–895.
Fidler, IJ, Talmadge, JE. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res 1986, 46:5167–5171.
Daves, MH, Hilsenbeck, SG, Lau, CC, Man, TK. Meta‐analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors. BMC Med Genomics 2011, 4:56. doi: 10.1186/1755‐8794‐4‐56.
van`t Veer, LJ, Dai, H, van de Vijver, MJ, He, YD, Hart, AA, Mao, M, Peterse, HL, van der Kooy, K, Marton, MJ, Witteveen, AT, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530–536. doi: 10.1038/415530a415530a.
Weigelt, B, Glas, AM, Wessels, LFA, Witteveen, AY, Peterse, JL, van`t Veer, LJ. Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 2003, 100:15901–15905. doi: 10.1073/pnas.26340671002634067100.
Brabletz, T, Jung, A, Spaderna, S, Hlubek, F, Kirchner, T. Opinion: migrating cancer stem cells ‐ an integrated concept of malignant tumour progression. Nat Rev Cancer 2005, 5:744–749. doi: 10.1038/nrc1694.
Hunter, K. Host genetics influence tumour metastasis. Nat Rev Cancer 2006, 6:141–146. doi: 10.1038/nrc1803.
Krimpenfort, P, Quon, KC, Mooi, WJ, Loonstra, A, Berns, A. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature 2001, 413:83–86. doi: 10.1038/35092584.
Crawford, NP, Ziogas, A, Peel, DJ, Hess, J, Anton‐Culver, H, Hunter, KW. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res 2006, 8:R16. doi: 10.1186/bcr1389.
Guilford, P, Hopkins, J, Harraway, J, McLeod, M, McLeod, N, Harawira, P, Taite, H, Scoular, R, Miller, A, Reeve, AE. E‐cadherin germline mutations in familial gastric cancer. Nature 1998, 392:402–405. doi: 10.1038/32918.
Lifsted, T, Le Voyer, T, Williams, M, Muller, W, Klein‐Szanto, A, Buetow, KH, Hunter, KW. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer 1998, 77:640–644.
Park, YG, Zhao, X, Lesueur, F, Lowy, DR, Lancaster, M, Pharoah, P, Qian, X, Hunter, KW. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet 2005, 37:1055–1062. doi: 10.1038/ng1635.
Winter, SF, Lukes, L, Walker, RC, Welch, DR, Hunter, KW. Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. PLoS Genet 2012, 8:e1002735. doi: 10.1371/journal.pgen.1002735.
Faraji, F, Pang, Y, Walker, RC, Nieves Borges, R, Yang, L, Hunter, KW. Cadm1 is a metastasis susceptibility gene that suppresses metastasis by modifying tumor interaction with the cell‐mediated immunity. PLoS Genet 2012, 8:e1002926. doi: 10.1371/journal.pgen.1002926.
Nicoloso, MS, Spizzo, R, Shimizu, M, Rossi, S, Calin, GA. MicroRNAs‐‐the micro steering wheel of tumour metastases. Nat Rev Cancer 2009, 9:293–302. doi: 10.1038/nrc2619.
Huang, Y, Shen, XJ, Zou, Q, Wang, SP, Tang, SM, Zhang, GZ. Biological functions of microRNAs: a review. J Physiol Biochem 2011, 67:129–139. doi: 10.1007/s13105‐010‐0050‐6.
Berezikov, E. Evolution of microRNA diversity and regulation in animals. Nat Rev Genet 2011, 12:846–860. doi: 10.1038/nrg3079.
Aigner, A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis‐related miRNAs. J Mol Med (Berl) 2011, 89:445–457. doi: 10.1007/s00109‐010‐0716‐0.
Ma, L, Teruya‐Feldstein, J, Weinberg, RA. Tumour invasion and metastasis initiated by microRNA‐10b in breast cancer. Nature 2007, 449:682–688. doi: 10.1038/nature06174.
Joyce, JA, Pollard, JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239–252. doi: 10.1038/nrc2618.
Hao, N‐B, Lü, M‐H, Fan, Y‐H, Cao, Y‐L, Zhang, Z‐R, Yang, S‐M. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012, 2012:948098. doi: 10.1155/2012/948098.
Bhowmick, NA, Neilson, EG, Moses, HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432:332–337. doi: 10.1038/nature03096.
Peinado, H, Alečković, M, Lavotshkin, S, Matei, I, Costa‐Silva, B, Moreno‐Bueno, G, Hergueta‐Redondo, M, Williams, C, García‐Santos, G, Ghajar, C, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro‐metastatic phenotype through MET. Nat Med 2012, 18:883–891. doi: 10.1038/nm.2753.
Ding, L, Ellis, MJ, Li, S, Larson, DE, Chen, K, Wallis, JW, Harris, CC, McLellan, MD, Fulton, RS, Fulton, LL, et al. Genome remodelling in a basal‐like breast cancer metastasis and xenograft. Nature 2010, 464:999–1005. doi: 10.1038/nature08989.
Dalerba, P, Kalisky, T, Sahoo, D, Rajendran, PS, Rothenberg, ME, Leyrat, AA, Sim, S, Okamoto, J, Johnston, DM, Qian, D, et al. Single‐cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 2011, 29:1120–1127. doi: 10.1038/nbt.2038.
Yanaihara, N, Caplen, N, Bowman, E, Seike, M, Kumamoto, K, Yi, M, Stephens, RM, Okamoto, A, Yokota, J, Tanaka, T, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189–198. doi: 10.1016/j.ccr.2006.01.025.
Yu, SL, Chen, HY, Chang, GC, Chen, CY, Chen, HW, Singh, S, Cheng, CL, Yu, CJ, Lee, YC, Chen, HS, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48–57. doi: 10.1016/j.ccr.2007.12.008.
Iorio, MV, Ferracin, M, Liu, CG, Veronese, A, Spizzo, R, Sabbioni, S, Magri, E, Pedriali, M, Fabbri, M, Campiglio, M, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65:7065–7070. doi: 10.1158/0008‐5472.Can‐05‐1783.
Iorio, MV, Visone, R, Di Leva, G, Donati, V, Petrocca, F, Casalini, P, Taccioli, C, Volinia, S, Liu, CG, Alder, H, et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67:8699–8707. doi: 10.1158/0008‐5472.Can‐07‐1936.
Michael, MZ, O`Connor, SM, Pellekaan, NGV, Young, GP, James, RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1:882–891.
Ma, L, Young, J, Prabhala, H, Pan, E, Mestdagh, P, Muth, D, Teruya‐Feldstein, J, Reinhardt, F, Onder, TT, Valastyan, S, et al. miR‐9, a MYC/MYCN‐activated microRNA, regulates E‐cadherin and cancer metastasis. Nat Cell Biol 2010, 12:247–256. doi: 10.1038/ncb2024.
Zhu, S, Si, ML, Wu, H, Mo, YY. MicroRNA‐21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007, 282:14328–14336. doi: 10.1074/jbc.M611393200.
Zhang, Y, Yang, P, Sun, T, Li, D, Xu, X, Rui, Y, Li, C, Chong, M, Ibrahim, T, Mercatali, L, et al. miR‐126 and miR‐126(*) repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat Cell Biol 2013, 15:284–294. doi: 10.1038/ncb2690.
Yang, H, Crawford, N, Lukes, L, Finney, R, Lancaster, M, Hunter, KW. Metastasis predictive signature profiles pre‐exist in normal tissues. Clin Exp Metastasis 2005, 22:593–603. doi: 10.1007/s10585‐005‐6244‐6.
Hu, Y, Wu, G, Rusch, M, Lukes, L, Buetow, KH, Zhang, J, Hunter, KW. Integrated cross‐species transcriptional network analysis of metastatic susceptibility. Proc Natl Acad Sci USA 2012, 109:3184–3189. doi: 10.1073/pnas.1117872109.
Quigley, DA, To, MD, Kim, IJ, Lin, KK, Albertson, DG, Sjolund, J, Pérez‐Losada, J, Balmain, A. Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility. Genome Biol 2011, 12:R5. doi: 10.1186/gb‐2011‐12‐1‐r5.
Lerebours, F, Cizeron‐Clairac, G, Susini, A, Vacher, S, Mouret‐Fourme, E, Belichard, C, Brain, E, Alberini, JL, Spyratos, F, Lidereau, R, et al. miRNA expression profiling of inflammatory breast cancer identifies a 5‐miRNA signature predictive of breast tumor aggressiveness. Int J Cancer 2013. doi: 10.1002/ijc.28171.
Ma, L, Reinhardt, F, Pan, E, Soutschek, J, Bhat, B, Marcusson, EG, Teruya‐Feldstein, J, Bell, GW, Weinberg, RA. Therapeutic silencing of miR‐10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010, 28:341–347. doi: 10.1038/nbt.1618.
Baffa, R, Fassan, M, Volinia, S, O`Hara, B, Liu, CG, Palazzo, JP, Gardiman, M, Rugge, M, Gomella, LG, Croce, CM, et al. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009, 219:214–221. doi: 10.1002/path.2586.
Jin, L, Zhang, Y, Li, H, Yao, L, Fu, D, Yao, X, Xu, LX, Hu, X, Hu, G. Differential secretome analysis reveals CST6 as a suppressor of breast cancer bone metastasis. Cell Res 2012, 22:1356–1373. doi: 10.1038/cr.2012.90.